Clinical effect of combination of octreotide and omeprazole in children with acute upper gastrointestinal bleeding and the levels of serum creatinine and serum urea nitrogen

Pak J Pharm Sci. 2022 Jan;35(1(Special)):343-347.

Abstract

Pediatric upper gastrointestinal bleeding refers to an acute massive hemorrhage of the upper digestive tract and biliary tract, which is a common clinical emergency in pediatrics. This study aimed to evaluate the clinical effect of octreotide combined with omeprazole in pediatric upper gastrointestinal bleeding. Totally 84 cases of pediatric upper gastrointestinal bleeding admitted to Ningbo Women and Children's Hospital from November 2019 to April 2021 were divided into groups according to the admission order. The control group received omeprazole treatment and the observation group received octreotide plus. The total clinical effective rate of children in the observation group was higher than that of the control group. The observation group was superior to the control group with respect to the average hemostasis time, hemostasis rate, rebleeding rate and length of stay after treatment. The observation group witnessed a significantly better quality of life than the control group. For children with acute upper gastrointestinal bleeding, the combination of omeprazole and octreotide yields a promising effect in the adjustment of blood creatinine and serum urea nitrogen levels and hemostasis, which is worthy of clinical application.

MeSH terms

  • Adolescent
  • Blood Urea Nitrogen*
  • Child
  • Child, Preschool
  • Creatinine / blood*
  • Drug Therapy, Combination
  • Female
  • Gastrointestinal Agents / administration & dosage
  • Gastrointestinal Agents / therapeutic use
  • Gastrointestinal Hemorrhage / drug therapy*
  • Humans
  • Male
  • Octreotide / administration & dosage
  • Octreotide / therapeutic use*
  • Omeprazole / administration & dosage
  • Omeprazole / therapeutic use*

Substances

  • Gastrointestinal Agents
  • Creatinine
  • Omeprazole
  • Octreotide